1、 姚春艳, 杨伉, 邓光贵. 尿微量白蛋白检测与糖尿病肾病[J]. 国外医学:临床生物化学与检验学分册,2001,21(12):121-122. 姚春艳, 杨伉, 邓光贵. 尿微量白蛋白检测与糖尿病肾病[J]. 国外医学:临床生物化学与检验学分册,2001,21(12):121-122.
2、 尹作骥.尿微量白蛋白联合脲酶检测在糖尿病.肾病早期诊断中的价值探讨[J]. 中国卫生检验杂志,2012,22(3):639-641. 尹作骥.尿微量白蛋白联合脲酶检测在糖尿病.肾病早期诊断中的价值探讨[J]. 中国卫生检验杂志,2012,22(3):639-641.
3、 ZHANG D, YANG H, KONG X,et al. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes[J]. Am J Physiol Endocrinol Metab,2011,300 (2): E287-295. ZHANG D, YANG H, KONG X,et al. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes[J]. Am J Physiol Endocrinol Metab,2011,300 (2): E287-295.
4、 RIGHETTONI M, TRICOLI A. Toward portable breath acetone analysis for diabetes detection[J]. J Breath Res, 2011, 5(3):037109. RIGHETTONI M, TRICOLI A. Toward portable breath acetone analysis for diabetes detection[J]. J Breath Res, 2011, 5(3):037109.
5、 王传发.糖尿病患者血清β-羟丁酸与血清酮体粉剂半定量法检测间的关系及价值研究[J]. 国际检验医学杂志,2010,31(7):673-674. 王传发.糖尿病患者血清β-羟丁酸与血清酮体粉剂半定量法检测间的关系及价值研究[J]. 国际检验医学杂志,2010,31(7):673-674.
6、 GRABOWSKA-POLANOWSKA B, FABER J, SKOWRON M,et al. New opportunities of renal diseases diagnostics using gas chromatography[J]. Przegl Lek, 2012,69(3):91-97. GRABOWSKA-POLANOWSKA B, FABER J, SKOWRON M,et al. New opportunities of renal diseases diagnostics using gas chromatography[J]. Przegl Lek, 2012,69(3):91-97.
7、 ZHOU M G, LIU Y,LI W W, et al. Investigation and identification of breath acetone as a potential biomarker for type 2 diabetes diagnosis[J]. Chin Sci Bull, 2014,24(17):1992-1998. ZHOU M G, LIU Y,LI W W, et al. Investigation and identification of breath acetone as a potential biomarker for type 2 diabetes diagnosis[J]. Chin Sci Bull, 2014,24(17):1992-1998.
8、 BEISSWENGER P J, HOWELL S K, RUSSELL G B, et al. Early progression of Diabetic Nephropathy correlates with methylglyoxal-derived advanced glycation end products[J]. Diabetes care,2013,36(10):3234. BEISSWENGER P J, HOWELL S K, RUSSELL G B, et al. Early progression of Diabetic Nephropathy correlates with methylglyoxal-derived advanced glycation end products[J]. Diabetes care,2013,36(10):3234.
9、 YANG S M, KA S M, WU H L, et al. Thrombomodulin domain l ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRP2 antioxidant activity and inhibition of apotosis[J]. Diabetologia, 2014,57(2):424-434. YANG S M, KA S M, WU H L, et al. Thrombomodulin domain l ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRP2 antioxidant activity and inhibition of apotosis[J]. Diabetologia, 2014,57(2):424-434.
10、 毕会民, 胡胜.2 型糖尿病患者脂蛋白-α 水平与尿白蛋白排泄率的关系[J]. 中华内分泌代谢杂志,2001,17 (5):311-312. 毕会民, 胡胜.2 型糖尿病患者脂蛋白-α 水平与尿白蛋白排泄率的关系[J]. 中华内分泌代谢杂志,2001,17 (5):311-312.
11、 包蕾.2 型糖尿病患者尿mAIb、β2-MG 及mAIb/Cr比值与HbA1c关系的研究[J]. 中国医学工程,2014,22(8):7-8. 包蕾.2 型糖尿病患者尿mAIb、β2-MG 及mAIb/Cr比值与HbA1c关系的研究[J]. 中国医学工程,2014,22(8):7-8.
12、 张学磊,金明花,王莹,等.糖尿病肾病患者血清瘦素水平变化与氧化应激的关系[J]. 中国医药导报,2016,13(16):54-57. 张学磊,金明花,王莹,等.糖尿病肾病患者血清瘦素水平变化与氧化应激的关系[J]. 中国医药导报,2016,13(16):54-57.
